Antibodies for obesity and other metabolic diseases
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
335
NCT01075204
Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)
Phase: N/A
Role: Collaborator
Start: Jan 31, 2011
Completion: Jan 31, 2012